Clinical trials
Observational Breast Neoplasms, Male trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 2 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Unknown status | 5 |
| Recruiting | 2 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Azerbaijan Medical University | 1 |
| Cancer Research UK | 1 |
| Cancer Trials Ireland | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Fox Chase Cancer Center | 1 |
| GenBasix Incorporated | 1 |
| Helios University Hospital Wuppertal | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms, Male | 29 |
| Breast Neoplasms | 25 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Colonic Neoplasms | 8 |
| Small Cell Lung Carcinoma | 6 |
| Colorectal Neoplasms | 5 |
| Lung Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Rectal Neoplasms | 5 |
| Neoplasms | 4 |
Trials
Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.